Blumea lacera DC., accelerates the healing of acetic acid induced ulcerative colitis in rats by regulating oxidative stress and colonic inflammation: in-vivo and in silico molecular docking experiments

다국어 초록 (Multilingual Abstract)

To expound the protective outcome of standardised hydroalcoholic extract of Blumea lacera (EEBL) in acetic acid-induced ulcerative colitis (UC). Further, in silico computational experiments were performed to identify the inhibitory activity of bioactive constituents of EEBL against inflammatory targets. Rats were pre-treated with EEBL (100 and 200 mg/kg) for 7 days and on eighth day, UC was induced by intrarectal instillation of 2 ml of 4% v/v acetic acid and treatment continues till 11th day. Colonic injury was examined by clinical activity score and mucosal inflammation was assessed by colon wet weight, macroscopic scoring and histopathological examination. In addition, colonic contractility studies and biochemical analysis were carried out. Further, bioactive compounds from title plant were subjected to drug likeness prediction and molecular docking studies against myeloid differentiation factor-2 (MD-2), nuclear factor-kappa B (NF-κB), tumor necrosis factor alpha (TNF-alpha) and soluble epoxide hydrolase (sEH). Pre-treatment with both the doses of EEBL significantly ameliorated the acetic acid-induced colonic injury and these results were parallels with biochemical and histopathology examinations. Out of fifteen selected bioactive compounds, 5-hydroxy-3methyl-3,6,7,4-tetramethoxy flavones, lachnophyllic acid and d-fenchone exhibited better drug likeness property with higher docking score. The observed protective outcome might be recognized due to the synergistic effect of identified bioactive compounds by inhibition of key targets of inflammation.

참고문헌 (Reference)

1 Van Rensburg SJ, "dehydro-epiandrosterone sulphate and melatonin on in vitro lipid peroxidation" 15 : 257-265, 2000

2 Rashmi Agarwal, "Triterpenoid and prenylated phenol glycosides from Blumea lacera" Elsevier BV 38 (38): 935-938, 1995

3 Charles N. Bernstein, "The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study" Elsevier BV 129 (129): 827-836, 2005

4 Nastaran Kordjazy, "Role of toll-like receptors in inflammatory bowel disease" Elsevier BV 129 : 204-215, 2018

5 Sagar Garud, "Review: Ulcerative colitis: current treatment strategies and future prospects" SAGE Publications 2 (2): 99-108, 2009

6 Boreddy Shivanandappa Thippeswamy, "Protective effect of embelin against acetic acid induced ulcerative colitis in rats" Elsevier BV 654 (654): 100-105, 2011

7 Santosh Basnet, "Protective effect of Blumea lacera DC aerial parts in indomethacin-induced enterocolitis in rats" Springer Science and Business Media LLC 23 (23): 355-363, 2015

8 Guang-Yu Yang, "Proinflammatory enzyme soluble epoxide hydrolase bridges obesity to colonic inflammation and potential carcinogenesis" Proceedings of the National Academy of Sciences 115 (115): 5827-5828, 2018

9 Fakhruddin Ali Ahmed, "Phytochemical composition, antioxidant activity and cytotoxicity of Blumea lacera Linn. from two different habitats" Bangladesh Journals Online (JOL) 3 (3): 37-45, 2016

10 Khair A, "Pharmacological activities of Blumea lacera (Burm. f) DC: a medicinal plant of Bangladesh" 4 : 1677-1687, 2014

11 Pan SY, "New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics" 2013 : 1-25, 2013

12 Mabozou Kpemissi, "Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: In-vitro, in-vivo and in-silico experiments" Elsevier BV 116 : 108961-, 2019

13 Singh MP, "Medicinal herbs with their formulations" Daya Publishing House 2005

14 Aisha Al-Jarallah, "Mechanism of reduced colonic contractility in experimental colitis: role of sarcoplasmic reticulum pump isoform-2" Springer Science and Business Media LLC 298 (298): 169-178, 2007

15 Clara Abraham, "Inflammatory Bowel Disease" Massachusetts Medical Society 361 (361): 2066-2078, 2009

16 Lien-Chai Chiang, "In vitro Anti-leukemic and Antiviral Activities of Traditionally Used Medicinal Plants in Taiwan" World Scientific Pub Co Pte Ltd 32 (32): 695-704, 2012

17 S Ekins, "In silico pharmacology for drug discovery: applications to targets and beyond" Wiley 152 (152): 21-37, 2007

18 Chan FK, "Immune homeostasis" Humana Press 65-70, 2013

19 Ramar V, "Exploring the inhibitory potential of bioactive compound from Luffa acutangula against NF-κB—A molecular docking and dynamics approach" Elsevier BV 62 : 29-35, 2016

20 Chandramohan V, "Evaluating andrographolide as a potent inhibitor of NS3-4A protease and its drug-resistant mutants using in silico approaches" 2015

21 A.G Jagtap, "Effect of polyherbal formulation on experimental models of inflammatory bowel diseases" Elsevier BV 90 (90): 195-204, 2004

22 Amir Ali Sohrabpour, "Current Therapeutic Approaches in Inflammatory Bowel Disease" Bentham Science Publishers Ltd. 16 (16): 3668-3683, 2010

23 I. Laakso, "Composition of the essential oil ofBlumea lacera DC. (Asteraceae) leaves from Nigeria" Wiley 4 (4): 73-75, 1989

24 Prabodh Satyal, "Chemical Composition of Blumea lacera Essential Oil from Nepal. Biological Activities of the Essential Oil and (Z)-Lachnophyllum Ester" SAGE Publications 10 (10): 2015

25 Rgia A Othman, "Beyond cholesterol-lowering effects of plant sterols: clinical and experimental evidence of anti-inflammatory properties" Oxford University Press (OUP) 69 (69): 371-382, 2011

26 Fabiana Andréa Moura, "Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?" Elsevier BV 6 : 617-639, 2015

27 Renata Fabia, "Acetic Acid-Induced Colitis in the Rat: A Reproducible Experimental Model for Acute Ulcerative Colitis" S. Karger AG 24 (24): 211-225, 1992